Technology News and Research

RSS

Volcano to distribute AngioSculpt PTCA Scoring Balloon Catheter in Japan

Volcano Corporation, a leading developer and manufacturer of precision intravascular therapy guidance tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it has entered into a distribution agreement with AngioScore for its AngioSculpt® PTCA Scoring Balloon Catheter for coronary indications in Japan. This is the first of what Volcano believes will be many products distributed by Volcano Japan, which now includes more than 50 direct sales representatives.

28 Apr 2010

Researchers develop new diagnostic approach to fight against Chagas disease

Chagas disease is one of the most deadly parasitic diseases in the world. It affects more than 10 million people, primarily in the Americas. In South America alone it kills 50 000 people each year. A reliable and rapid diagnosis is the key in the battle against infection but until now, this has been next to impossible.

28 Apr 2010

Myriad Genetics OnDose collection kit eliminates need for frozen sample handling

Myriad Genetics, Inc. today announced a significant improvement in the sample collection kit for OnDoseTM, its 5-Fluorouracil (5-FU) dose optimization product. Patient sample handling can now be conducted at room temperature, eliminating the need for frozen sample handling. Myriad said that it believes the simplified process should increase physician acceptance and utilization of OnDose.

28 Apr 2010

Study results from US Military Malaria Vaccine Program announced

Bioject Medical Technologies Inc., a leading developer of needle-free injection therapy systems, today announced that the US Military Malaria Vaccine Program presented results of its study using the Biojector2000 with a recombinant DNA vaccine at two recent conferences. A Cooperative Research and Development Agreement was signed with the Navy in April 2009 to work together on the study.

28 Apr 2010

Boston-Power announces lithium-ion battery technology for medical device and equipment market

Boston-Power®, Inc., the rapidly growing provider of next-generation lithium-ion batteries, is responding to strong customer and partner demand by bringing its industry-leading lithium-ion battery technology to the multi-billion dollar global medical device and equipment market. Boston-Power's lithium-ion battery cells deliver unmatched levels of long life, fast charge and safety to a market that demands the most stringent standards of battery reliability to ensure that patients receive the highest quality of care.

28 Apr 2010

Tel Aviv University researcher pioneers 3-D occupational therapy for children with disabilities

It was her love of ballet that led her to work with children who have motor disabilities. The retired dancer, now an occupational therapist, is pioneering a new "virtual" method to analyze movement patterns in children ― and more effectively treat those with debilitating motor disorders.

28 Apr 2010

Healthline Networks raises $14M through third round of financing led by IGC

Healthline Networks, the leading provider of intelligent health information services, today announced that it has raised $14 million in a third round of financing led by Investor Growth Capital (IGC), the wholly owned venture capital arm of Investor AB (Investor). The round also includes strategic financing from GE/NBC Universal's Peacock Equity Fund, a joint venture between GE Capital's Media, Communications & Entertainment business and NBC Universal and Reed Elsevier Ventures.

28 Apr 2010

PAREXEL's consolidated service revenue for third-quarter 2010 increases 10.1% to $291.2M

PAREXEL International Corporation today announced its financial results for the third quarter ended March 31, 2010.

From Parexel 28 Apr 2010

Phase II clinical trial to test safety and efficacy of transplanted encapsulated islets

The Juvenile Diabetes Research Foundation announced today that it is partnering with Living Cell Technologies, a New Zealand-based biotechnology company focused on developing cell based therapeutics, in a Phase II clinical trial to study the safety and effectiveness of transplanting encapsulated insulin-producing cells from pigs as a treatment for type 1 diabetes with significant hypoglycemia unawareness.

28 Apr 2010

MHS announces completion of $7.0 million Series B equity investment

Management Health Solutions, Inc. (MHS), a leading provider of supply chain management solutions to hospitals and healthcare providers across the United States, announced today the completion of a $7.0 million Series B equity investment led by Enhanced Equity Fund, L.P. (Enhanced Equity). Radius Ventures, LLC (Radius), the company's existing institutional investor, also participated in the financing round.

28 Apr 2010

SI-BONE to present iFuse MIS procedure at WCMISST 2010

SI-BONE, Inc., a medical device company that is pioneering the use of a minimally invasive surgical device to treat the sacroiliac joint today announced that iFuse initial post-market clinical experience will be presented at upcoming 2010 minimally invasive spine surgery meetings.

28 Apr 2010

Life Technologies first-quarter non-GAAP 2010 revenue increases 13% to $887 million

Life Technologies Corporation today announced results for its first quarter ending March 31, 2010. Non-GAAP revenue for the first quarter was $887 million, an increase of 13 percent over the $785 million reported for the first quarter of 2009. Excluding the impact of currency and completed acquisitions and divestitures, organic revenue for the quarter grew 10 percent over the same period in the previous year.

28 Apr 2010

TYRX receives FDA marketing clearance for AIGISRx ST antibacterial patch for soft tissue repair

TYRX, Inc. announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market AIGISRx® ST, its antibacterial product for the surgical repair of damaged or ruptured soft tissue.

28 Apr 2010

CSI granted FDA unconditional IDE approval for trial of Diamondback 360 System in coronary arteries

Cardiovascular Systems, Inc., has received Food and Drug Administration unconditional Investigational Device Exemption (IDE) approval, allowing the company to proceed with ORBIT II, a pivotal trial to evaluate the safety and effectiveness of CSI's Diamondback 360® System in the coronary arteries. CSI received conditional IDE approval for the ORBIT II study in January 2010.

28 Apr 2010

BioMedix TRAKnet software suite receives APMA Seal of Acceptance

Today, the BioMedix TRAKnet software suite was granted the prestigious American Podiatric Medical Association (APMA) Seal of Acceptance. BioMedix is the only company to receive the APMA Seal of Acceptance for Electronic Health Record and Practice Management software.

28 Apr 2010

Antares Pharma, Uman Pharma announce strategic alliance for VIBEX MTX

Antares Pharma, Inc., a leader in self-injection drug delivery technology and Uman Pharma, a manufacturer of top-quality injectable pharmaceutical products based in Quebec, Canada, today announced the formation of a strategic alliance covering Antares' VIBEX™ MTX.

27 Apr 2010

Penalties and fines for sending non-encrypted e-mails including patient information

A new law that took effect in February calls for substantial new penalties on doctors for something they are doing every day – sending e-mails that include patient information, without encrypting the e-mail.

27 Apr 2010

Amedisys' first-quarter 2010 net service revenues up 20.8%

Amedisys, Inc., one of America's leading home health nursing companies, today reported its financial results for the three-month period ended March 31, 2010. We posted record financial performance with net service revenue and net income attributable to Amedisys, Inc., increasing 20.8% and 35.6%, respectively, over the three-month period ended March 31, 2009.

27 Apr 2010

MMC announces acquisition of BGR.com

Mail.com Media Corporation, the digital media company that owns and operates the Mail.com portal and email service as well as a growing portfolio of lifestyle brands including, Deadline.com, HollywoodLife.com, Movieline.com and OnCars.com, announced today its acquisition of BGR.com, one of the top mobile/gadget sites in the world.

27 Apr 2010

DNASTAR, Scarab Genomics announce launch of DNA and RNA sequencing services business

DNASTAR and Scarab Genomics, sister companies founded by genomics pioneer Fred Blattner, announce the launch of a next-generation DNA and RNA sequencing services business. Using their combined expertise, the companies will be offering a full range of sequencing services including library preparation, coordinating the most appropriate sequencing technology and platform, assembly, analysis, annotation, and visualization of end results.

27 Apr 2010

Technology News and Research

Volcano to distribute AngioSculpt PTCA Scoring Balloon Catheter in Japan

Researchers develop new diagnostic approach to fight against Chagas disease

Myriad Genetics OnDose collection kit eliminates need for frozen sample handling

Study results from US Military Malaria Vaccine Program announced

Boston-Power announces lithium-ion battery technology for medical device and equipment market

Tel Aviv University researcher pioneers 3-D occupational therapy for children with disabilities

Healthline Networks raises $14M through third round of financing led by IGC

PAREXEL's consolidated service revenue for third-quarter 2010 increases 10.1% to $291.2M

Phase II clinical trial to test safety and efficacy of transplanted encapsulated islets

MHS announces completion of $7.0 million Series B equity investment

SI-BONE to present iFuse MIS procedure at WCMISST 2010

Life Technologies first-quarter non-GAAP 2010 revenue increases 13% to $887 million

TYRX receives FDA marketing clearance for AIGISRx ST antibacterial patch for soft tissue repair

CSI granted FDA unconditional IDE approval for trial of Diamondback 360 System in coronary arteries

BioMedix TRAKnet software suite receives APMA Seal of Acceptance

Antares Pharma, Uman Pharma announce strategic alliance for VIBEX MTX

Penalties and fines for sending non-encrypted e-mails including patient information

Amedisys' first-quarter 2010 net service revenues up 20.8%

MMC announces acquisition of BGR.com

DNASTAR, Scarab Genomics announce launch of DNA and RNA sequencing services business

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News